 |
|
|
March 16, 2005 FlowMedica's BENEPHIT™ Delta Infusion System Receives 510(k) Clearance. - full story March 15, 2005 BENEPHIT™ Infusion System To Be Studied In Patients With Chronic Kidney Disease Undergoing Cardiovascular Procedures - full story March 14, 2005 Quick Study Radiology Announces Three New Clients - full story March 10, 2005 Researchers Discover Gene Believed Responsible for Age-Related Macular Degeneration - full story March 10, 2005 FDA Accepts for Review Insmed's NDA for SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome - full story March 01, 2005 PreGen-Plus Meets All Criteria of Blue Shield’s California Technology Assessment Forum - full story February 17, 2005 Flowmedica’s BENEPHIT™ Infusion System Receives CE Marking - full story February 08, 2005 IMCOR Pharmaceutical Co. Receives Notice of Allowance from US Patent and Trademark Office of IMCOR's Patent Application for Imagent Entitled "Ultrasound Imaging System Utilizing a Long-Persistence Agent" - full story February 03, 2005 FDA Accepts Nitromed’s New Drug Application Resubmission for BiDil® - full story February 01, 2005 SEQUENOM Announces Identification of Second Breast Cancer Gene - full story January 31, 2005 Flowmedica Announces New Physician-Sponsored Study of its BENEPHITtm Infusion System in Patients with Renal Insufficiency - full story January 12, 2005 AtheroGenics Completes Sale of $200 Million Convertible Notes - full story January 11, 2005 BiDil® Named to American Heart Association’s 2004 ‘Top 10 Advances’ List - full story January 06, 2005 Acusphere's AI-700 Pilot Study Exceeds Expectations - full story December 22, 2004 New England Journal of Medicine Reports That Stool-Based DNA Test is Four-Times More Sensitive Than Fecal Occult Blood Test for Colorectal Cancer Screening - full story December 07, 2004 IMCOR Pharmaceutical Co. Announces the Commencement of a Phase 2 Repeat Dosing Clinical Trial - full story November 22, 2004 AtheroGenics Reports Positive Final Results from CART-2 Clinical Trial of AGI-1067 - full story November 15, 2004 FDA Clears superDimension/Bronchus - full story November 01, 2004 Bristol-Myers Squibb Medical Imaging and IMCOR Pharmaceutical Co. Enter into Cross-Licensing Agreement for Ultrasound Contrast Patents - full story October 11, 2004 superDimension Announces Opening of US Headquarters - full story |
September 15, 2004 FlowMedica Completes $5.6 Million Series C Financing - full story August 31, 2004 NitroMed Issued Additional Patent Covering the Use of BiDil for the Treatment of Heart Failure in African Americans - full story August 2, 2004 IMCOR Pharmaceutical Names Brian M. Gallagher, Ph.D. and Darlene M. Deptula-Hicks to its Board of Directors and Elects Dr. Gallagher as Chairman of the IMCOR Board of Directors - full story July 19, 2004 Nitromed Stops Heart Failure Study (A-HeFT) in African Americans Due to Significant Survival Benefit of BIDIL® - full story July 15, 2004 superDimension Applied Successfully to Lymph Node Aspiration at the Asklepios Clinic in Munich, Germany - full story July 12, 2004 MassARRAY™ System Enables Detection of Fetal Genetic Mutations in Maternal Plasma - full story July 7, 2004 Acusphere Announces $70 Million European Partnership for AI-700 - full story June 22, 2004 Merck and NitroMed Advance First Nitric Oxide-Enhancing COX-2 Inhibitor Into Phase II Clinical Testing - full story May 17, 2004 MIT's Technology Review Magazine Names superDimensionTM/Bronchus Among Top Five "Killer Patents" for 2003 - full story April 14, 2004 IMCOR Pharmaceutical Co. Receives Commitments for $10 Million Equity Financing - full story March 31, 2004 Sequenom MassARRAY™ System Used to Identify Diabetes Risk Gene - full story March 31, 2004 Market Research Points to Likely Positive Impact of PreGen-Plus on Colorectal Cancer Screening Rates - full story March 25, 2004 AtheroGenics Names Robert P. Ryan, Ph.D. as Vice President of Regulatory Affairs - full story March 25, 2004 FlowMedica Announces Post-Market Study of its BENEPHIT™ INFUSION SYSTEM - full story March 16, 2004 NitroMed Announces interim Analysis of A-HeFT Trial; Planned Interim Safety Analysis Conducted - full story February 19, 2004 FlowMedica Receives 510(k) Clearance from FDA for its Bifurcated Infusion System - full story February 12, 2004 FlowMedica Names Vartan Ghazarossian President and CEO - full story February 10, 2004 Sequenom Reports Fourth Quarter and Year-End Financial Results - full story January 14, 2004 Quick Study Radiology Continues to Set Growth Records - full story January 12, 2004 AtheroGenics announces Collaboration with Fujisawa to Develop AGI-1096 for Transplant Rejection - full story |